סודיום כלוריד % 0.9 לעירוי לתוך הוריד BP ישראל - עברית - Ministry of Health

סודיום כלוריד % 0.9 לעירוי לתוך הוריד bp

teva medical marketing ltd. - sodium chloride - תמיסה לאינפוזיה - sodium chloride 0.9 %w/v - sodium chloride - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.

סודיום כלוריד % 0.9 לעירוי לתוך הוריד BP ישראל - עברית - Ministry of Health

סודיום כלוריד % 0.9 לעירוי לתוך הוריד bp

teva medical marketing ltd. - sodium chloride - תמיסה לאינפוזיה - sodium chloride 0.9 %w/v - sodium chloride - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.

סודיום כלוריד % 0.9 לעירוי לתוך הוריד BP ישראל - עברית - Ministry of Health

סודיום כלוריד % 0.9 לעירוי לתוך הוריד bp

teva medical marketing ltd. - sodium chloride - תמיסה לאינפוזיה - sodium chloride 0.9 %w/v - sodium chloride

PRIMERO - P קרם לעור בעייתי ישראל - עברית - Ministry of Health

primero - p קרם לעור בעייתי

ס.מ חומרים טבעיים - לטיפוח עור בעייתי

דיקלופלסט ישראל - עברית - Ministry of Health

דיקלופלסט

cts ltd - diclofenac sodium - מדבקות - diclofenac sodium 140 mg/patch - diclofenac - diclofenac - dicloplast is indicated for topical treatment of rheumatic diseases, pain and non-infectious inflammation.

דיקלופלסט ישראל - עברית - Ministry of Health

דיקלופלסט

cts ltd - diclofenac sodium - מדבקות - diclofenac sodium 140 mg - diclofenac - diclofenac - dicloplast is indicated for topical treatment of rheumatic diseases, pain and non-infectious inflammation.

סוויס רליף דואל רליס ישראל - עברית - Ministry of Health

סוויס רליף דואל רליס

padagis israel agencies ltd, israel - diclofenac sodium - קפסולות - diclofenac sodium 75 mg - diclofenac - diclofenac - as a non-steroidal anti-inflamatory analgesic in symptomatic management of rheumatoid arthritis osteoarthritis and ankylosying spondylitis acute musculo-skeletal disorders such as periarthritis tendenitis tensynovitis bursitis sprains strains and dislocations relief of pain in fractures low back pain acute gout psoriatic arthropathy. in the management of pain and inflammation associated with orthopaedic dental and minor surgery.

פרבליפ 40 ישראל - עברית - Ministry of Health

פרבליפ 40

unipharm ltd, israel - pravastatin sodium - טבליה - pravastatin sodium 40 mg - pravastatin - pravastatin - pravastatin is indicated as a component of multiple risk factor intervention in those individuals at increased risk for atherosclerotic vascular disease due to hypercholesterolemia . pravastatin should be used in addition to a diet other nonpharmacological measures alone have been inadequate. primary prevention of coronary events: in hypercholesterolemic patients wihthout clinically evident coronary heart disease pravastatin is indicated to: 1) reduce the risk of myocardial infarcton. 2) reduce the risk for revascularization. 3) reduce the risk of deaths due to cardiovascular causes with no increase in death due to non-cardiovascular causes. secondary prevention of cardiovascular events: a) atherosclerosis: in hypercholesterolemic patients with clinically evident coronary artery disease including prior mi pravastatin is indicated to: 1)slow the progression of coronary atherosclerosis. 2) reduce the risk of acute coronary events. b) myocardial infarction: in patients with previous myocardial infarction and nor

פרבליפ 10 ישראל - עברית - Ministry of Health

פרבליפ 10

unipharm ltd, israel - pravastatin sodium - טבליה - pravastatin sodium 10 mg - pravastatin - pravastatin - pravastatin is indicated as a component of multiple risk factor intervention in those individuals at increased risk for atherosclerotic vascular disease due to hypercholesterolemia . pravastatin should be used in addition to a diet and other nonpharmacological measures alone has been inadequate. primary prevention of coronary events: in hypercholesterolemic patients wihthout clinically evident coronary heart disease pravastatin is indicated to: 1) reduce the risk of myocardial infarcton. 2) reduce the risk for revascularization. 3) reduce the risk of deaths due to cardiovascular causes with no increase in death non-cardiovascular causes. secondary prevention of cardiovascular events: a) atherosclerosis: in hypercholesterolemic patients with clinically evident coronary artery disease including prior mi pravastatin is indicated to: 1)slow the progression of coronary atherosclerosis. 2) reduce the risk of acute coronary events. b) myocardial infarction: in patients with previous myocardial infarction and normal

פרבליפ 20 ישראל - עברית - Ministry of Health

פרבליפ 20

unipharm ltd, israel - pravastatin sodium - טבליה - pravastatin sodium 20 mg - pravastatin